NVS
Novartis·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NVS Profile
Novartis Ag
A Swiss leading global medicines company that develops branded and generic pharmaceuticals, consmer health products, vaccines and diagnostics
Pharmaceutical
02/29/1996
05/12/2000
New York Stock Exchange
75,883
12-31
Depository Receipts (Ordinary Shares)
Lichtstrasse 35, 4056 Basel, Switzerland
Research, develop, manufacture and sell patented medicines in the fields of cancer and blood diseases
Novartis AG was established in Switzerland on February 29, 1996. The Company is an innovative drug company engaged in the research, development, manufacturing, distribution, marketing and sales of various innovative drugs. The company's mission is to use its scientific expertise to find new ways to treat and cure diseases and reimagine medicine to improve and prolong people's lives. The company's business is divided into five organizational divisions: biomedical research, development, operations and two commercial divisions (US and International). Global functions support the work of these organizational units. The company focuses on four core therapeutic areas with strong growth potential and a large number of unmet patient needs — cardiovascular, renal and metabolism; immunology; neuroscience; and oncology.
